Summary
Global Markets Direct’s “Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review†is an in-depth business, strategic and financial analysis of Cougar Biotechnology, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Cougar Biotechnology, Inc. (Cougar) is a biotechnology company engaged in in-licensing and developing clinical stage pharmaceutical products for the treatment of Cancer for commercial use. The company’s in-licensing product candidates include CB7630, CB3304, CB1089, and CB6604. The company is headquartered in Los Angeles, United States. On May 21, 2009, Johnson & Johnson and Cougar Biotechnology, Inc. entered into a definitive agreement whereby Cougar Biotechnology will be acquired for approximately $1.0 billion in a cash tender offer.
Recent Developments
Jun 17, 2009: Johnson & Johnson Receives Regulatory Clearance For Acquisition Of Cougar
Jul 03, 2009: Cougar Reports Successful Completion Of J&J' Initial Tender Offer
Jul 10, 2009: Johnson & Johnson Completes Acquisition Of Cougar
Scope
- Provides key company information for business intelligence needs
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- A quick “one-stop-shop†to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial & strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitors’ weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.